PRESS RELEASE

Of interest to editors and journalists covering:
Medical Research and Technology, Biotech, Gene Research, GA News


Health Discovery Corporation Announces Agreement with the University of Miami for Biomarker and Pathway
Discovery in AIDS related Dementia

SAVANNAH, GA - March 23, 2004 /Send2Press Newswire/ -- Health Discovery Corporation (OTC Bulletin Board:
HDVY) today announced the signing of an Agreement with The University of Miami  to use Health Discovery
Corporations proprietary and patent protected Fractal Genomics Modeling (FGM) techniques to identify new
patterns of biomarkers in AIDS Related Dementia. It is hoped that this newly discovered information will
allow physicians to better understand the pathogenesis of AIDS Related Dementia and will assist in the
diagnosis and treatment of this devastating disease. Under the terms of the Agreement, The University of
Miami has granted Health Discovery Corporation joint ownership on any product, invention, discovery or
new use arising out of or developed by Health Discovery Corporation utilizing its unique computational
methods.

"We are honored that our Company was again selected by yet another major United States medical center to
utilize our unique approach to systems biology; this time to discover new patterns of biomarkers and
pathways associated with AIDS Related Dementia," stated Stephen D. Barnhill, M.D., Chairman and Chief
Executive Officer of Health Discovery Corporation. "We look forward to working with Dr. Shapshak and his
colleagues Drs. Carol Petito, Jorge Torres-Munoz, and Avindra Nath at U of Miami and Johns Hopkins
Medical Center on this very important discovery opportunity."

Dr. Paul Shapshak commented, "Applying the Fractal non-linear information methodology is the most
exciting technology in modern science and takes us into the 22nd Century. I am thankful and excited to
work with Dr. Barnhill and his team at Health Discovery Corporation in this endeavor. They will have a
leadership role in gene expression, bioinformatics and other new methods to defeat disease." Dr. Shapshak
continued, "Diseases of the present and future beware!"

Estimates of the incidence of HIV-associated dementia vary, depending on the definition of dementia being
used. Researchers from the John Hopkins University have estimated that 15% of HIV-infected people may
develop dementia and that 30% may show some signs of neurological impairment (McArthur 1999).

Health Discovery Corporation is a systems biology oriented biomarker and pathway discovery company, which
uses proprietary advanced mathematical platforms, such as Fractal Genomics Modeling (FGM) techniques, to
help identify and characterize diagnostic targets and therapeutic candidates. Focusing on disease vs.
normal, within complex genomic, proteomic and clinical data sets, Health Discovery Corporation was
established to provide pharmaceutical and diagnostic companies with a broad range of analytical and
decision support solutions to accelerate effective diagnostic and drug discovery. Founded in September
2003, the Company has offices in Texas, Georgia, and California. For more information contact Robert S.
Braswell IV of Health Discovery Corporation +1-866-953-9031 or Info@healthdiscoverycorp.com.

This news release contains "forward-looking statements" within the meaning of Section 27a of the
Securities Acts of 1933 and Section 21E of the Securities Exchange Act of 1934. Although the Company
believes that the expectations reflected in such forward-looking statements are reasonable, it can give
no assurance that such expectations will prove correct.


	MEDIA CONTACT:
	Robert S. Braswell IV 
	of Health Discovery Corporation 
	+1-866-953-9031
	info@healthdiscoverycorp.com


( OTC Bulletin Board: HDVY )

 
# # #


[ source of news = Health Discovery Corporation ]
ref: http://www.send2press.com/2archive/2004/pr_04_0323-hdvy.txt
	 http://www.send2press.com/2archivePDF/pr_04_0323-hdvy.pdf
---------------------------------------------------------------------------
*IMPORTANT NOTE TO MEDIA:
	to reach the organization releasing this news, please contact:
	info@healthdiscoverycorp.com (media only)
	
	If used for publication, please send specimen copy.
---------------------------------------------------------------------------
S2PRN-R/6c/ GA / SAVANNAH, Georgia / Copr. (c) 2004 Send2Press.


This release was issued on behalf of the above organization,
who is solely responsible for accuracy of content,
by Send2Press(tm), a unit of Neotrope(R). http://www.Send2Press.com